Discovery, Structure-Based Modification, In Vitro, In Vivo, and In Silico Exploration of m-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer’s Disease-Reference-Cited by-同舟云学术

Discovery, Structure-Based Modification, In Vitro, In Vivo, and In Silico Exploration of m-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer’s Disease

Published:2024-03-07 Issue:6 Volume:15 Page:1135-1156
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Lu Xin¹²³,Li Yueqing⁴,Guan Qianwen²,Yang Huajing⁵,Liu Yijun²,Du Chenxi²,Wang Lei²,Wang Qinghua²,Pei Yuqiong⁵,Wu Liang⁵,Sun Haopeng²^ORCID,Chen Yao⁵

Affiliation:

1. Department of Pharmacy, College of Medicine, Institute of Translational Medicine, Yangzhou University, Yangzhou 225001, People’s Republic of China

2. School of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China

3. Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225001, People’s Republic of China

4. Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, People’s Republic of China

5. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, People’s Republic of China

Funder

Qinglan Project of Jiangsu Province of China

???333 Project??? of Jiangsu Province

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00737

Reference44 articles.